Abstract
Cancer remains one of the leading causes of mortality worldwide, and its effective treatment continues to be a significant challenge. Over the past decades, nanomedicine has emerged as a valuable addition to the therapeutic arsenal in the fight against cancer. Among the available approaches, albumin nanoparticles (HSA-PNPs) stand out due to their simplicity of preparation, versatility in …